The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

Use of hypoglossal nerve stimulation (HGNS) may be effective for treating obstructive sleep apnea (OSA), but a higher body mass index (BMI) and supine sleeping position may decrease effects, according ...

If you’ve struggled with this treatment, nerve stimulation may offer a path forward. Previously, people with moderate to severe OSA “who were intolerant to CPAP machines had no other treatment options ...

A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up ...

The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...

A nerve stimulator implant called Inspire is helping some sleep apnea patients breathe normally at night when a CPAP machine is not an effective treatment. Millions of Americans suffer from sleep ...

CHICAGO -- An investigational proximal hypoglossal nerve stimulation device helped control obstructive sleep apnea (OSA), the OSPREY randomized trial showed. The Apnea-Hypopnea Index (AHI) response ...

To qualify for the device, called a hypoglossal nerve stimulator, a person over 18 diagnosed with moderate-to-severe obstructive sleep apnea must be unable to adapt or refuse to wear a continuous ...

Leading Sleep Surgeon Dr. Jordan Weiner Brings Cutting-Edge CPAP Alternative to Arizona Patients SCOTTSDALE, AZ, UNITED STATES, February 13, 2026 /EINPresswire.com ...

Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the senior and corresponding author and Brian Skotko, MD, MPP, the director of the Down ...

The FDA has elevated a recall of Inspire Medical’s nerve-stimulating implant for the treatment of obstructive sleep apnea. The agency handed down a Class I recall designation to the effort, its most ...